Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Shareholders' Equity

v3.19.3.a.u2
Condensed Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid- In Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings (Accumulated Deficit)
Beginning balance at Sep. 30, 2018 $ 93,090 $ 142 $ 124,316 $ (9,974) $ (21,394)
Beginning balance (in shares) at Sep. 30, 2018   14,217,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (2,372)       (2,372)
Translation adjustment (576)     (576)  
Stock compensation expense 169   169    
Stock options exercised 37   37    
Stock options exercised (in shares)   11,000      
Ending balance at Dec. 31, 2018 90,348 $ 142 124,522 (10,550) (23,766)
Ending balance (in shares) at Dec. 31, 2018   14,228,000      
Beginning balance at Sep. 30, 2019 $ 87,452 $ 143 125,098 (11,233) (26,556)
Beginning balance (in shares) at Sep. 30, 2019 14,268,797 14,269,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss $ (1,932)       (1,932)
Translation adjustment 2,673     2,673  
Stock compensation expense 68   68    
Stock options exercised 701 $ 1 700    
Stock options exercised (in shares)   117,000      
Ending balance at Dec. 31, 2019 $ 88,962 $ 144 $ 125,866 $ (8,560) $ (28,488)
Ending balance (in shares) at Dec. 31, 2019 14,386,422 14,386,000